Senators pressure HHS over prediction markets on drug trials.
According to Crypto Briefing, U.S. senators questioned the Department of Health and Human Services (HHS) about prediction markets tied to drug trials. The report says the rise of these markets could undermine trial integrity, public trust, and ethical standards in medical research.
· HHS is the subject of the inquiry, which focuses on prediction markets around trial stages.
· The reported concerns are trial integrity and public trust; the senators’ specific demands were not disclosed.
Should drug trial results become tradable contracts?
According to Crypto Briefing, U.S. senators questioned the Department of Health and Human Services (HHS) about prediction markets tied to drug trials. The report says the rise of these markets could undermine trial integrity, public trust, and ethical standards in medical research.
· HHS is the subject of the inquiry, which focuses on prediction markets around trial stages.
· The reported concerns are trial integrity and public trust; the senators’ specific demands were not disclosed.
Should drug trial results become tradable contracts?
